Sigrun Hallmeyer Selected Research

Sigrun Hallmeyer Research Topics

8	Melanoma (Melanoma, Malignant) 01/2021 - 01/2014
2	Neoplasms (Cancer) 01/2017 - 01/2014
1	COVID-19 02/2022
1	Breast Neoplasms (Breast Cancer) 01/2022
1	Atrophy 10/2018
1	Cardiotoxicity 10/2018
1	Oligohydramnios 01/2017
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2017
1	Disease Progression 10/2016
1	Colitis 01/2016
1	Brain Neoplasms (Brain Tumor) 01/2014
1	Prostatic Neoplasms (Prostate Cancer) 09/2006

5	IpilimumabIBA 01/2021 - 01/2014
3	Interleukin-2 (IL2)IBA 01/2017 - 01/2016
2	VemurafenibIBA 12/2017 - 01/2014
2	Immune Checkpoint InhibitorsIBA 10/2016 - 01/2016
1	Immunoglobulin G (IgG)IBA 02/2022
1	Zoledronic Acid (Zometa)FDA Link 01/2022
1	Ibandronic Acid (Boniva)FDA Link 01/2022
1	human ERBB2 proteinIBA 01/2022
1	hydroxide ionIBA 01/2022
1	Clodronic Acid (Clodronate)IBA 01/2022
1	Diphosphonates (Bisphosphonates)IBA 01/2022
1	Denosumab FDA Link 01/2022
1	Hormones (Hormone)IBA 01/2022
1	aldesleukin (Proleukin)FDA Link 01/2021
1	pembrolizumabIBA 01/2021
1	LubricantsIBA 10/2018
1	Codon (Codons)IBA 12/2017
1	Trastuzumab (Herceptin)FDA Link 01/2017
1	talimogene laherparepvecIBA 12/2016
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 12/2016
1	Peptides (Polypeptides)IBA 09/2006
1	prostate-specific antigen (146-154)IBA 09/2006